Free Cash Flow: A measure of financial performance calculated as operating cash flow minus capital expenditures. Calculated as: Cash Flow from Operations + Net Property, Plant & Equipment Exp (a negative number)
ImmuCell Corporation (ICCC) had Free Cash Flow of $3.41M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$10.36M |
|
$1.94M |
|
$5.70M |
|
$4.66M |
|
$8.39M |
|
$1.97M |
|
$-0.02M |
|
$1.95M |
|
$1.95M |
|
$1.94M |
|
$1.94M |
|
$1.94M |
|
$1.94M |
|
$1.97M |
|
$2.50M |
|
9.05M |
|
9.05M |
|
$0.21 |
|
$0.21 |
|
| Balance Sheet Financials | |
$18.86M |
|
$20.78M |
|
$25.25M |
|
$44.11M |
|
$3.91M |
|
$7.07M |
|
$11.06M |
|
$14.97M |
|
$29.14M |
|
$29.04M |
|
$29.14M |
|
9.05M |
|
| Cash Flow Statement Financials | |
$3.57M |
|
$-0.17M |
|
$-0.40M |
|
$3.81M |
|
$6.81M |
|
$3.01M |
|
$0.14M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.82 |
|
-- |
|
-- |
|
0.20 |
|
0.30 |
|
44.97% |
|
19.01% |
|
19.01% |
|
-- |
|
18.87% |
|
18.75% |
|
|
Free Cash Flow |
$3.41M |
-- |
|
-- |
|
-- |
|
0.23 |
|
0.66 |
|
3.84 |
|
23.41 |
|
6.66% |
|
6.69% |
|
4.40% |
|
5.36% |
|
$3.22 |
|
$0.38 |
|
$0.40 |
|